These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8137523)
1. Alpha 2-adrenergic activity is normal in patients with thyroid disease. Del Rio G; Zizzo G; Marrama P; Venneri MG; Della Casa L; Velardo A Clin Endocrinol (Oxf); 1994 Feb; 40(2):235-9. PubMed ID: 8137523 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and catecholamine response to clonidine in obese subjects. Del Rio G; Zizzo G; Bonati ME; Macdonald IA; Velardo A Int J Obes Relat Metab Disord; 1995 Jul; 19(7):475-9. PubMed ID: 8520637 [TBL] [Abstract][Full Text] [Related]
3. Sex differences in catecholamine response to clonidine. Del Rio G; Verlardo A; Zizzo G; Marrama P; Della Casa L Int J Obes Relat Metab Disord; 1993 Aug; 17(8):465-9. PubMed ID: 8401749 [TBL] [Abstract][Full Text] [Related]
4. The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy. Del Rio G; Carani C; Velardo A; Procopio M; Zizzo G; Savio P; Mantovani R; Marrama P; Ghigo E J Endocrinol Invest; 1996 Sep; 19(8):505-10. PubMed ID: 8905472 [TBL] [Abstract][Full Text] [Related]
5. Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits. Szabo B; Hedler L; Starke K Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):648-57. PubMed ID: 2615856 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and metabolic responses to adrenaline infusion in patients with short-term hypothyroidism. Johnson AB; Webber J; Mansell P; Gallen I; Allison SP; Macdonald I Clin Endocrinol (Oxf); 1995 Dec; 43(6):747-51. PubMed ID: 8736279 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma. McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397 [TBL] [Abstract][Full Text] [Related]
8. Plasma catecholamines after thyrotropin-releasing hormone administration in hypothyroid patients before and during therapy. Velardo A; Del Rio G; Zizzo G; Venneri MG; Della Casa L; Marrama P Eur J Endocrinol; 1994 Mar; 130(3):220-3. PubMed ID: 8156093 [TBL] [Abstract][Full Text] [Related]
9. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood. Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Zoukos Y; Thomaides T; Pavitt DV; Leonard JP; Cuzner ML; Mathias CJ Clin Auton Res; 1992 Jun; 2(3):165-70. PubMed ID: 1323363 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical responses to nadolol and clonidine in hyperthyroidism. Herman VS; Joffe BI; Kalk WJ; Panz V; Wing J; Seftel HC J Clin Pharmacol; 1989 Dec; 29(12):1117-20. PubMed ID: 2693501 [TBL] [Abstract][Full Text] [Related]
12. Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine. Zoukos Y; Thomaides T; Chaudhuri KR; Pavitt DV; Cuzner ML; Mathias CJ Blood Press; 1994 May; 3(3):172-7. PubMed ID: 8069405 [TBL] [Abstract][Full Text] [Related]
13. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms. Bouloux PM; Corsello S; Besser M; Grossman A Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322 [TBL] [Abstract][Full Text] [Related]
15. Decreased sensitivity to alpha-adrenergic stimulation in hypothyroid patients. Polikar R; Kennedy B; Ziegler M; Smith J; Nicod P J Clin Endocrinol Metab; 1990 Jun; 70(6):1761-4. PubMed ID: 2347907 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats. Brown MJ; Harland D Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737 [TBL] [Abstract][Full Text] [Related]
17. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats. Yorimitsu M; Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yokotani K Life Sci; 2008 Feb; 82(9-10):487-94. PubMed ID: 18201726 [TBL] [Abstract][Full Text] [Related]
18. Alpha-2 adrenergic activity in perimenopausal women. Del Rio G; Menozzi R; Della Casa L; Venneri MG; Zizzo G; Marrama P; Velardo A J Endocrinol Invest; 1997 Nov; 20(10):603-10. PubMed ID: 9438918 [TBL] [Abstract][Full Text] [Related]
19. Value of the clonidine suppression test in the diagnosis of pheochromocytoma. Karlberg BE; Hedman L Acta Med Scand Suppl; 1986; 714():15-21. PubMed ID: 3472437 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. Veith RC; Best JD; Halter JB J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]